Sort
24,576 grants matching “microbiome”
Novel Pathways for Kidney Stone Formation
$784,903Eric N Taylor · Brigham And Women'S Hospital · R01 · FY2019 · DK
Biobehavioral Mechanistic Model of Alcohol Use Following Bariatric Surgery: The BREW ME Model
$784,687Scott G Engel · Sanford Research North · R01 · FY2024 · AA
Investigating nanobodies to target multidrug resistant bacterial pathogens
$784,687Bryan William Davies · University Of Texas At Austin · R01 · FY2020 · AI
Toxoplasma Surface Antigens and Immunity
$784,656Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Vibrio cholerae antinitrosative stress defenses and gut microbiome interaction
$784,506Jun Zhu · University Of Pennsylvania · R01 · FY2022 · AI
Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study
$784,467Vaia Lida Chatzi · University Of Southern California · U01 · FY2025 · HG
Next Generation Multipurpose Intravaginal Ring Technology Using Innovative CLIP 3D Printing
$784,402Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Mechanisms of multi-species bacterial interactions
$784,374Anupama Khare · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Nutrition, terminal NAD metabolites and cardiovascular disease
$784,329Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL
Nutrition, terminal NAD metabolites and cardiovascular disease
$784,329Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
Integrated genomics research in parasitic tropical diseases
$784,316Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2014 · AI
Impact of microbiota on AIDS-Kaposiâs sarcoma development and therapy
$784,127Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$784,076Craig R Cohen · University Of California, San Francisco · R01 · FY2019 · HD
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
$783,841Jeffrey P Krischer · University Of South Florida · R01 · FY2016 · HD
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2025 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2024 · AI
Intestinal microbiota-mediated rotavirus vaccine failure
$783,735Andrew T Gewirtz · Georgia State University · R01 · FY2023 · AI
Natural History of C. trachomatis urogenital and rectal infections
$783,622Deborah Anne Dean · University Of California, San Francisco · R01 · FY2024 · AI
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study
$783,342Kevin James Downes · Children'S Hosp Of Philadelphia · R01 · FY2024 · HD
Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV
$783,330Canhua Xiao · Emory University · R01 · FY2023 · DE
Maternal and Infant Microbiome Determinants of Brain and Behavioral Development
$783,172Christopher L. Coe · University Of Wisconsin-Madison · R33 · FY2016 · MH
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
$783,147Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2025 · AI
Identification and Characterization of Microbial Metabolites in Immunity
$783,068Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2022 · AI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity
$782,960Loris Y. Hwang · University Of California Los Angeles · R01 · FY2019 · AI
Training in Pediatric Gastroenterology, Hepatology, and Nutrition
$782,824Scott B Snapper · Boston Children'S Hospital · T32 · FY2025 · DK